An international study carried out with involvement of the MedUni Vienna is giving hope to patients with advanced prostate cancer.
In just a few years’ time, Ipilumumab could be approved as a treatment for the world’s third-most common type of cancer.
The immunotherapeutic agent Ipilumumab has been shown to have a markedly positive effect in the treatment of patients who are resistant to conventional hormone treatments and chemotherapy. These are the words of a core statement from a study, recently published in the highly respected journal “The Lancet Oncology”, which was set up based on collaboration between the world’s leading centres for the research and treatment of prostate cancer.
The scientists investigated the extent to which immunotherapy with this agent is also suitable for the more common type of advanced prostate cancer. The medication is already being successfully used as immunotherapy for advanced melanoma – a comparatively rare type of cancer.
Read more . . .
The Latest on: Immunotherapy
[google_news title=”” keyword=”Immunotherapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Immunotherapy
- Researchers find difference in pancreatic cancer cells, offering new hope for immunotherapy effectivenesson May 1, 2024 at 6:32 am
Abdelrahim and his collaborators established a hypothesis that there is a difference in microenvironments of tumors in the pancreatic head versus the body and tail, particularly the immunotherapy ...
- New gene signature could transform immunotherapy for gastrointestinal cancerson April 30, 2024 at 1:31 pm
Despite significant progress in treating gastrointestinal (GI) cancers through surgical resection, chemotherapy, radiotherapy, and targeted therapy, the objective response rate (ORR) for immune ...
- Breaking: AI Could Transform Cancer Treatment by Predicting Immunotherapy Successon April 30, 2024 at 8:27 am
In this article, we’ll explore a breakthrough development in the fight against cancer: how artificial intelligence (AI) is poised to predict immunotherapy success. This has the potential to ...
- Immunotherapy Safe And Effective Against Allergies In Kids Under 5on April 30, 2024 at 5:01 am
Immunotherapy is a safe and effective treatment against allergies in children under 5 years of age, doctors said on Thursd ...
- Immunotherapy: A Beacon of Hope in Cancer Treatmenton April 29, 2024 at 11:38 pm
Cancer, a disease that has plagued humanity for centuries, has finally met its match in immunotherapy, a revolutionary treatment that harnesses the power of the immune system to combat this deadly ...
- New Guideline Recommends Chemotherapy With Immunotherapy in Advanced SCLCon April 29, 2024 at 6:00 am
Updated guidelines for small cell lung cancer were developed with an expert panel assembled by the American Society of Clinical Oncology and Ontario Health.
- Pre-Ketone Supplement With Immunotherapy Shows Promise for Prostate Cancer in Miceon April 28, 2024 at 5:00 pm
Subscribe for FREE “Prostate cancer is the most common cancer for American men, and immunotherapy has been really influential in some other cancers, like melanoma or lung cancer, but it hasn’t been ...
- Immunotherapy and hay feveron April 26, 2024 at 2:09 am
Hope is at hand, however, in the form of immunotherapy. The most acute hay fever sufferers are sometimes referred for the treatment, and now new research "highlighting its effectiveness" may lead to ...
- Vitamin D may balance gut microbiome to give cancer immunotherapy a booston April 25, 2024 at 12:30 pm
A new study in mice found that dietary vitamin D plays a role in balancing the gut microbiome and improving the way cancer immunotherapy works to fight tumors.
- Scientists making progress in less toxic cancer treatment called immunotherapyon April 22, 2024 at 3:04 pm
Scientists are making progress in using less toxic immunotherapy instead of traditional chemotherapy to fight cancer.
via Bing News
